Financials

  • Market Capitalization 1.51 B
  • Employee 159
  • Founded 1996
  • CEO N/A
  • Website www.inva.com
  • Headquarter Delaware, United States
  • FIGI BBG000CG9XT7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
6.06
Rapporto prezzo/fatturato
4.12

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2178
LBRX
LB Pharmaceuticals Inc - Common Stock
47.89 USD-0.58%+0.38%+36.28%+152.05%1.54 B USD
2181
AVBP
ArriVent BioPharma, Inc. - Common Stock
31.00 USD-0.45%+5.19%+3.58%+61.63%1.53 B USD
2199
NVAX
Novavax, Inc. - Common Stock
9.05 USD-1.74%+7.23%+24.14%+19.71%1.49 B USD
2211
REPL
Replimune Group, Inc. - Common Stock
15.60 USD-1.76%+12.55%+197.14%+191.04%1.47 B USD

Notizie